10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2015

Filing Information

Form Type	10-Q
Accession Number	`0001144204-15-047730`
Period End Date	20150630
Filing Date	20150810
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	bpth-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 44 Cash Flow Statement 32

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$11.08M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$13.86M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$3.55M	USD	Point-in-time
Cash	`Cash`	$15.72M	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$154.67K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$695.84K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$253.62K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$100.49K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$12.03M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.11M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.41K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.41K	USD	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$10.28K	USD	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$30.85K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$92.56K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$113.13K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.25M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.33M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.17M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.25M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$13.29M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.48M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$41.03K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$385.07K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$100.45K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$253.44K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$307.13K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$67.05K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$692.20K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$561.97K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$692.20K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$561.97K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 6/30/15 and 12/31/14, respectively	`CommonStockValue`	$89.76K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 6/30/15 and 12/31/14, respectively	`CommonStockValue`	$89.76K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$34.93M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$34.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-22.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.92M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$14.92M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$12.60M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$15.48M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$13.29M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$517.04K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$564.35K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$624.68K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.16M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.35M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$754.55K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$566.59K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.14M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.79M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.27M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.51M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.13M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.13M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.27M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.79M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.51M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$9.65K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$6.07K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$11.64K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.40K	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	-	USD	2 Qtrs
Other expense	`OtherNonoperatingExpense`	$42.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$281.00	USD	2 Qtrs
Other expense	`OtherNonoperatingExpense`	-	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$5.40K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$6.02K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$11.36K	USD	2 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$9.65K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-2.50M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-1.27M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.77M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.24M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.24M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	1 Quarter

Cash Flow Statement 32 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.50M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.27M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$80.31K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$80.31K	USD	2 Qtrs
Depreciation	`Depreciation`	$20.57K	USD	2 Qtrs
Depreciation	`Depreciation`	-	USD	2 Qtrs
Stock-based compensation and warrants	`ShareBasedCompensation`	$184.56K	USD	2 Qtrs
Stock-based compensation and warrants	`ShareBasedCompensation`	$209.07K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$541.18K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$89.98K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$153.12K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$107.45K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$130.23K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$38.62K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.78M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.64M	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.81M	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	-	USD	2 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$13.81M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-2.78M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$12.17M	USD	2 Qtrs
Cash, beginning of period	`Cash`	$11.08M	USD	Point-in-time
Cash, beginning of period	`Cash`	$13.86M	USD	Point-in-time
Cash, beginning of period	`Cash`	$3.55M	USD	Point-in-time
Cash, beginning of period	`Cash`	$15.72M	USD	Point-in-time
Cash, end of period	`Cash`	$11.08M	USD	Point-in-time
Cash, end of period	`Cash`	$13.86M	USD	Point-in-time
Cash, end of period	`Cash`	$3.55M	USD	Point-in-time
Cash, end of period	`Cash`	$15.72M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.